Ibrahim Kays

Ibrahim Kays is a highly experienced scientist with a strong background in neuroscience and drug discovery. Currently a Senior Scientist at Rgenta Therapeutics Inc. since September 2020, Ibrahim also serves as the Founder of Geneboost, established to accelerate early drug discovery. Previously, Ibrahim completed a Postdoctoral Fellowship at the Centre universitaire de santé McGill | McGill University Health Centre, focusing on pharmacological therapies for neurological diseases and developing a patented high-throughput drug screening platform. Ibrahim's doctoral research at McGill University involved innovative techniques to quantify protein levels and analyze neuronal branching patterns, contributing to several high-impact publications. Ibrahim holds a Ph.D. in Neuroscience and a Bachelor's degree in Biology from McGill University.